C. Pászty

发表

Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis

Qing Chen, Tom Boone, Raj Haldankar, 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Transcriptional Profiling of Laser Capture Microdissected Subpopulations of the Osteoblast Lineage Provides Insight Into the Early Response to Sclerostin Antibody in Rats

Yudong D. He, P. Nioi, H. Hamadeh, 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease.

E. Rubin, H. Witkowska, N. Mohandas, 1997, Science.

Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male rats

P. Kostenuik, M. Stolina, H. Ke, 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Protein 4.1R-deficient mice are viable but have erythroid membrane skeleton abnormalities.

J. Conboy, V. Afzal, B. Coller, 1999, The Journal of clinical investigation.

Lethal α–thalassaemia created by gene targeting in mice and its genetic rescue

E. Rubin, J. Loring, S. Liebhaber, 1995, Nature Genetics.

Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones

D. Lacey, Susan Y. Smith, M. Stolina, 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Increased bone formation and bone mass induced by sclerostin antibody is not affected by pretreatment or cotreatment with alendronate in osteopenic, ovariectomized rats.

P. Kostenuik, M. Stolina, H. Ke, 2011, Endocrinology.

Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice.

E. Rubin, N. Maeda, J. Verstuyft, 1994, The Journal of clinical investigation.

Stomatocytosis is absent in "stomatin"-deficient murine red blood cells.

N. Mohandas, F. Kuypers, T. Turetsky, 1999, Blood.

Rapid Publication

E. Rubin, N. Maeda, C. Pászty, 2022 .

Inhibition of WISE preserves renal allograft function.

W. Richards, K. Graham, M. Damore, 2013, Journal of the American Society of Nephrology : JASN.

Glycophorin A dimerization and band 3 interaction during erythroid membrane biogenesis: in vivo studies in human glycophorin A transgenic mice.

C. Huang, N. Mohandas, J. Chasis, 2001, Blood.

Transgenic and gene knock‐out mouse models of sickle cell anemia and the thalassemias

C. Pászty, 1997, Current opinion in hematology.

Lethal alpha-thalassaemia created by gene targeting in mice and its genetic rescue.

E. Rubin, J. Loring, N. Mohandas, 1995, Nature genetics.

In vivo blood flow abnormalities in the transgenic knockout sickle cell mouse.

N. Mohandas, A. Cheung, C. Pászty, 1999, The Journal of clinical investigation.

Increased callus mass and enhanced strength during fracture healing in mice lacking the sclerostin gene.

H. Ke, H. Tan, W. S. Simonet, 2011, Bone.

Targeted Deletion of the Sclerostin Gene in Mice Results in Increased Bone Formation and Bone Strength

P. Kostenuik, S. Morony, D. Lacey, 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Rapid Genotyping of Mice with Hemoglobinopathies and Globin Transgenes

E. Rubin, W. Shehee, Jada Lewis, 1998, Biochemical Genetics.

Characterization of the Structural Features and Interactions of Sclerostin

P. Slocombe, M. Carr, F. Muskett, 2009, Journal of Biological Chemistry.

Apolipoprotein B RNA editing enzyme-deficient mice are viable despite alterations in lipoprotein metabolism.

J. Morrison, E. Rubin, J. Scott, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Sclerostin: A gem from the genome leads to bone‐building antibodies

C. Turner, M. Robinson, C. Pászty, 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength

Daniel J Lightwood, D. Lacey, Susan Y. Smith, 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Sclerostin Inhibition Reverses Skeletal Fragility in an Lrp5-Deficient Mouse Model of OPPG Syndrome

A. Robling, M. Warman, C. Pászty, 2013, Science Translational Medicine.

Magnetic resonance evidence of hypoxia in a homozygous alpha-knockout of a transgenic mouse model for sickle cell disease.

J. Gore, E. Rubin, R. Nagel, 1996, The Journal of clinical investigation.

Rational design of an animal model for alzheimer's disease: introduction of multiple human genomic transgenes to reproduce AD pathology in a rodent

J. Trojanowski, V. Lee, J. Loring, 1996, Neurobiology of Aging.

Treatment with a sclerostin antibody increases cancellous bone formation and bone mass regardless of marrow composition in adult female rats.

W. Jee, H. Ke, R. Setterberg, 2010, Bone.

Sclerostin antibody increases bone mass by stimulating bone formation and inhibiting bone resorption in a hindlimb-immobilization rat model.

W. Jee, H. Ke, X. Tian, 2011, Bone.

Rajendra Kedlaya Mouse Model of OPPG Syndrome Sclerostin Inhibition Reverses Skeletal Fragility in an Lrp 5-Deficient

A. Robling, M. Warman, C. Pászty, 2013 .

Rapid Publication Magnetic Resonance Evidence of Hypoxia in a Homozygous Alpha-Knockout of a Transgenic Mouse Model for Sickle Cell Disease

J. Gore, E. Rubin, R. Nagel, 2013 .

Inhibition of transgene expression in plant protoplasts by the presence in cis of an opposing 3′-promoter

C. Pászty, P. Lurquin, 1990 .

Increased bone formation and bone mass induced by sclerostin antibody is not affected by pretreatment or cotreatment with alendronate in osteopenic, ovariectomized rats.

P. Kostenuik, M. Stolina, H. Ke, 2011, Endocrinology.